Kidney Cancer Rx Approved in Europe
Kidney cancer doesn’t usually have any warning signs until it has become pretty serious. In fact, about a third of patients are diagnosed with an advanced stage of the disease. A medication has been approved in Europe to treat kidney cancer that has spread.
FDA Approves Inlyta to Treat Patients With a Type of Advanced Kidney Cancer
The U.S. Food and Drug Administration today approved Inlyta ( axitinib ) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.